vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and TRIMAS CORP (TRS). Click either name above to swap in a different company.

Astera Labs, Inc. is the larger business by last-quarter revenue ($308.4M vs $256.5M, roughly 1.2× TRIMAS CORP). TRIMAS CORP runs the higher net margin — 31.9% vs 26.0%, a 5.8% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (93.4% vs 3.8%). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (100.3% CAGR vs 3.3%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.

ALAB vs TRS — Head-to-Head

Bigger by revenue
ALAB
ALAB
1.2× larger
ALAB
$308.4M
$256.5M
TRS
Growing faster (revenue YoY)
ALAB
ALAB
+89.6% gap
ALAB
93.4%
3.8%
TRS
Higher net margin
TRS
TRS
5.8% more per $
TRS
31.9%
26.0%
ALAB
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
100.3%
3.3%
TRS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ALAB
ALAB
TRS
TRS
Revenue
$308.4M
$256.5M
Net Profit
$80.3M
$81.7M
Gross Margin
76.3%
12.8%
Operating Margin
20.1%
5.7%
Net Margin
26.0%
31.9%
Revenue YoY
93.4%
3.8%
Net Profit YoY
152.4%
236.9%
EPS (diluted)
$0.44
$2.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
TRS
TRS
Q1 26
$308.4M
$256.5M
Q4 25
$270.6M
$-140.0M
Q3 25
$230.6M
$269.3M
Q2 25
$191.9M
$274.8M
Q1 25
$159.4M
$241.7M
Q4 24
$141.1M
$-66.2M
Q3 24
$113.1M
$229.4M
Q2 24
$76.8M
$240.5M
Net Profit
ALAB
ALAB
TRS
TRS
Q1 26
$80.3M
$81.7M
Q4 25
$45.0M
$81.7M
Q3 25
$91.1M
$9.3M
Q2 25
$51.2M
$16.7M
Q1 25
$31.8M
$12.4M
Q4 24
$24.7M
$5.6M
Q3 24
$-7.6M
$2.5M
Q2 24
$-7.5M
$10.9M
Gross Margin
ALAB
ALAB
TRS
TRS
Q1 26
76.3%
12.8%
Q4 25
75.6%
Q3 25
76.2%
12.8%
Q2 25
75.8%
13.8%
Q1 25
74.9%
13.6%
Q4 24
74.0%
Q3 24
77.7%
15.4%
Q2 24
77.9%
14.4%
Operating Margin
ALAB
ALAB
TRS
TRS
Q1 26
20.1%
5.7%
Q4 25
24.7%
Q3 25
24.0%
6.2%
Q2 25
20.7%
9.9%
Q1 25
7.1%
9.0%
Q4 24
0.1%
Q3 24
-7.9%
3.6%
Q2 24
-31.7%
7.4%
Net Margin
ALAB
ALAB
TRS
TRS
Q1 26
26.0%
31.9%
Q4 25
16.6%
-58.4%
Q3 25
39.5%
3.5%
Q2 25
26.7%
6.1%
Q1 25
20.0%
5.1%
Q4 24
17.5%
-8.5%
Q3 24
-6.7%
1.1%
Q2 24
-9.8%
4.5%
EPS (diluted)
ALAB
ALAB
TRS
TRS
Q1 26
$0.44
$2.03
Q4 25
$0.25
$2.01
Q3 25
$0.50
$0.23
Q2 25
$0.29
$0.41
Q1 25
$0.18
$0.30
Q4 24
$1.23
$0.14
Q3 24
$-0.05
$0.06
Q2 24
$-0.05
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
TRS
TRS
Cash + ST InvestmentsLiquidity on hand
$148.3M
$30.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$705.6M
Total Assets
$1.7B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
TRS
TRS
Q1 26
$148.3M
$30.0M
Q4 25
$167.6M
$30.0M
Q3 25
$140.4M
$33.6M
Q2 25
$162.3M
$30.3M
Q1 25
$86.4M
$32.7M
Q4 24
$79.6M
$23.1M
Q3 24
$126.1M
$26.9M
Q2 24
$421.1M
$35.0M
Total Debt
ALAB
ALAB
TRS
TRS
Q1 26
Q4 25
$469.2M
Q3 25
$407.1M
Q2 25
$424.5M
Q1 25
$434.2M
Q4 24
$398.1M
Q3 24
$409.9M
Q2 24
$427.4M
Stockholders' Equity
ALAB
ALAB
TRS
TRS
Q1 26
$1.5B
$705.6M
Q4 25
$1.4B
$705.6M
Q3 25
$1.3B
$725.0M
Q2 25
$1.1B
$715.3M
Q1 25
$1.0B
$686.6M
Q4 24
$964.8M
$667.3M
Q3 24
$889.6M
$682.8M
Q2 24
$845.3M
$675.9M
Total Assets
ALAB
ALAB
TRS
TRS
Q1 26
$1.7B
$1.5B
Q4 25
$1.5B
$1.5B
Q3 25
$1.4B
$1.4B
Q2 25
$1.3B
$1.4B
Q1 25
$1.1B
$1.4B
Q4 24
$1.1B
$1.3B
Q3 24
$983.1M
$1.4B
Q2 24
$915.5M
$1.4B
Debt / Equity
ALAB
ALAB
TRS
TRS
Q1 26
Q4 25
0.66×
Q3 25
0.56×
Q2 25
0.59×
Q1 25
0.63×
Q4 24
0.60×
Q3 24
0.60×
Q2 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
TRS
TRS
Operating Cash FlowLast quarter
$74.6M
$117.5M
Free Cash FlowOCF − Capex
$36.8M
FCF MarginFCF / Revenue
14.4%
Capex IntensityCapex / Revenue
18.9%
Cash ConversionOCF / Net Profit
0.93×
1.44×
TTM Free Cash FlowTrailing 4 quarters
$109.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
TRS
TRS
Q1 26
$74.6M
$117.5M
Q4 25
$95.3M
$41.5M
Q3 25
$78.2M
$36.5M
Q2 25
$135.4M
$30.3M
Q1 25
$10.5M
$9.2M
Q4 24
$39.7M
$27.1M
Q3 24
$63.5M
$22.0M
Q2 24
$29.8M
$18.4M
Free Cash Flow
ALAB
ALAB
TRS
TRS
Q1 26
$36.8M
Q4 25
$76.6M
$36.8M
Q3 25
$65.9M
$22.8M
Q2 25
$133.3M
$13.2M
Q1 25
$6.0M
$-3.8M
Q4 24
$24.3M
$12.1M
Q3 24
$46.8M
$10.2M
Q2 24
$28.5M
$7.5M
FCF Margin
ALAB
ALAB
TRS
TRS
Q1 26
14.4%
Q4 25
28.3%
-26.3%
Q3 25
28.6%
8.5%
Q2 25
69.5%
4.8%
Q1 25
3.7%
-1.6%
Q4 24
17.2%
-18.3%
Q3 24
41.4%
4.4%
Q2 24
37.1%
3.1%
Capex Intensity
ALAB
ALAB
TRS
TRS
Q1 26
18.9%
Q4 25
6.9%
-3.4%
Q3 25
5.3%
5.1%
Q2 25
1.1%
6.2%
Q1 25
2.8%
5.4%
Q4 24
10.9%
-22.6%
Q3 24
14.8%
5.2%
Q2 24
1.7%
4.5%
Cash Conversion
ALAB
ALAB
TRS
TRS
Q1 26
0.93×
1.44×
Q4 25
2.12×
0.51×
Q3 25
0.86×
3.92×
Q2 25
2.64×
1.81×
Q1 25
0.33×
0.74×
Q4 24
1.61×
4.80×
Q3 24
8.71×
Q2 24
1.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons